Ronald Reagan UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles, in Westwood, Los Angeles, California, United States. It is currently ranked the 3rd best hospital in the United States by U.S. News & World Report, and 1st on the West Coast.

During the past decade, Ronald Reagan UCLA Medical Center conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 90 clinical trials were completed, i.e. on average, 67.2% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 54 clinical trials were completed. i.e. 93.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ronald Reagan UCLA Medical Center" #1 sponsor was "Pfizer" with 51 trials, followed by "University of California, Los Angeles" with 27 trials sponsored, "Abbott Medical Devices" with 8 trials sponsored, "Boston Scientific Corporation" with 7 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ronald Reagan UCLA Medical Center" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 12 trials as a collaborator, "Medical University of South Carolina" with 11 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "University of California, Los Angeles" with 5 trials as a collaborator. Other collaborators include 155 different institutions and companies that were collaborators in the rest 129 trials.

According to Clinical.Site data, the most researched conditions in "Ronald Reagan UCLA Medical Center" are "Stroke" (7 trials), "Acute Myeloid Leukemia" (6 trials), "Covid19" (6 trials), "Pulmonary Arterial Hypertension" (6 trials) and "COVID-19" (5 trials). Many other conditions were trialed in "Ronald Reagan UCLA Medical Center" in a lesser frequency.

Most popular intervention types in "Ronald Reagan UCLA Medical Center" are "Drug" (121 trials), "Device" (37 trials), "Biological" (28 trials), "Other" (17 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Docetaxel" (4 trials), "Remdesivir" (4 trials), "Cryoablation" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ronald Reagan UCLA Medical Center" are 182 trials for "All" genders, 10 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are 63 active trials in "Ronald Reagan UCLA Medical Center". 1 are not yet recruiting, 33 are recruiting, 24 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 91 completed trials in Ronald Reagan UCLA Medical Center, undefined suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Ronald Reagan UCLA Medical Center, 37 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 34 trials that are defined as “Not Applicable".

Ronald Reagan UCLA Medical Center has several departments that took part in Clinical trials: "UCLA Division of Rheumatology" - 22 trials, "UCLA David Geffen School of Medicine, Division of Rheumatology" - 12 trials, "UCLA Neuropsychiatric Institute & Hospital" - 2 trials, "Daniel Furst, MD" - 2 trials